Bringing Groundbreaking Treatments to Patients with Psychiatric and Neurodegenerative Diseases

Unleashing unique propepties and biological effects of Noble gases for treatment of PTSD, Autism, Dementia

Combining revolutionary portable inhalation device with a safe therapeutic

Accelerated pathway of clinical development

Nobilis Therapeutics is developing proprietary inhalation-based therapeutics using controlled self-administration of inert gases to address unmet medical need in the treatment of psychiatric and neurodegenerative diseases.

By leveraging data on more than 500 patients successfully treated for conditions ranging from panic disorder to autoimmune diseases, Nobilis has coupled its patent pending gas mixtures with a proprietary inhalational device to offer reproducible, standardized, and controlled patient exposure. The Company is currently advancing its technologies into human clinical trials.

Twitter Feed

Nobilis Therapeutics @NobilisTx
Nobilis Therapeutics’ leadership will attend J.P.Morgan’s 36th Annual Healthcare Conference. If you are interested… https://t.co/SiYO0ellPU
h J R
Nobilis Therapeutics @NobilisTx
Memory engrams. This field is truly fascinating! https://t.co/IGFD68rro3
h J R
Nobilis Therapeutics @NobilisTx
Discussing our PTSD clinical program with Congressman Duncan Hunter https://t.co/tUOI99UoVn
h J R
Nobilis Therapeutics @NobilisTx
With Dr. Ed Meloni after a successful pre-IND meeting https://t.co/yQN3w1ZKAP
h J R